Previous close | 6.25 |
Open | N/A |
Bid | 3.10 |
Ask | 7.20 |
Strike | 25.00 |
Expiry date | 2024-11-15 |
Day's range | 6.25 - 6.25 |
Contract range | N/A |
Volume | |
Open interest | 1 |
As global markets experience fluctuations influenced by economic data and geopolitical tensions, investors are keenly watching the U.S. market for stable investment opportunities. High insider ownership in growth companies can be a strong signal of confidence in the company’s future, making such stocks potentially attractive in these uncertain times.
Corcept Therapeutics ( NASDAQ:CORT ) First Quarter 2024 Results Key Financial Results Revenue: US$146.8m (up 39% from...
Corcept (CORT) beats on both earnings and sales in the first quarter of 2024. The company increases revenue guidance for 2024.